Capivasertib China PK Study

NCT04742036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumours

Interventions

DRUG: Capivasertib
DRUG: Paclitaxel

Sponsor

AstraZeneca